SCHEMBL16435722

SCHEMBL16435722

CN(CCN(C)C(C)(C)C)C(=O)c1cccnc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.49
ATM Q13315 1/20 0.49
MLYCD O95822 1/20 0.48
HTT P42858 1/20 0.48
LMNA P02545 2/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP11B1 P15538 1/20 0.46
CYP11B2 P19099 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
NPSR1 Q6W5P4 2/20 0.45
TSHR P16473 2/20 0.45
USP2 O75604 1/20 0.45
TP53 P04637 1/20 0.45
ALOX15 P16050 1/20 0.45
MAPK1 P28482 1/20 0.45
HSD17B10 Q99714 1/20 0.45
MAPT P10636 1/20 0.45
GFER P55789 1/20 0.45
THRB P10828 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9763463 0.89 HTT (0.56) KDM4EMLYCDHTTLMNANPSR1
SCHEMBL15477469 0.85 HTT (0.52) KDM4EMLYCDHTTLMNANPSR1
SCHEMBL31707265 0.82 HTT (0.52) KDM4EMLYCDHTTLMNANPSR1
SCHEMBL24508715 0.82 HTT (0.52) KDM4EMLYCDHTTLMNANPSR1
SCHEMBL16219420 0.82 KDM4E (0.65) KDM4EATMMLYCDHDAC1HDAC6
SCHEMBL18650142 0.81 HTT (0.51) KDM4EMLYCDHTTLMNACYP1A2
SCHEMBL8841639 0.79 MLYCD (0.55) KDM4EMLYCDHTTLMNACYP1A2
SCHEMBL30476608 0.79 HTT (0.63) KDM4EMLYCDHTTLMNANPSR1
SCHEMBL27670331 0.79 HTT (0.55) KDM4EMLYCDHTTLMNANPSR1
SCHEMBL2111661 0.79 HTT (0.63) KDM4EMLYCDHTTLMNANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9221822-B2 Thiazolopyrimidine modulators as immunosuppressive agents KATHOLIEKE UNIVERSITEIT LEUVEN, K. U. LEUVEN R&D (BE) 2015-12-29 US disclosed
US-20150038494-A1 Thiazolopyrimidine Modulators as Immunosuppressive Agents KATHOLIEKE UNIVERSITEIT LEUVEN, K.U.LEUVEN R&D (BE) 2015-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150038494-A1 Thiazolopyrimidine Modulators as Immunosuppressive Agents TPMT, STAT6, IL4 KDM4E 1646/4885ATM 3094/4885MLYCD 4161/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.